Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_assertion type Assertion NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_head.
- NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_assertion description "[Logistic regression analysis demonstrated that female gender (odds ratio [OR], 10.913; 95% confidence interval [CI], 1.778 to 66.97; p = 0.01) and BAC, including adenocarcinomas with any bronchioloalveolar features (OR, 9.708; 95% CI, 1.464 to 64.393; p = 0.019), were significantly associated with EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_provenance.
- NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_assertion evidence source_evidence_literature NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_provenance.
- NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_assertion SIO_000772 16002952 NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_provenance.
- NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_assertion wasDerivedFrom befree-2016 NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_provenance.
- NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_assertion wasGeneratedBy ECO_0000203 NP502971.RAt6dM-QpI2K_sj1_MJLpTmU85oCILCaSqdWycW87fkfE130_provenance.